483
Views
13
CrossRef citations to date
0
Altmetric
Research Article

A cardiopulmonary study of lisdexamfetamine in adults with attention-deficit/hyperactivity disorder

, , , , , , & show all
Pages 299-306 | Received 15 Nov 2011, Accepted 27 Feb 2012, Published online: 06 May 2012

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

John J. Mariani, C. Jean Choi, Martina Pavlicova, Amy L. Mahony, Daniel J. Brooks, John Grabowski & Frances R. Levin. (2021) Open‐label pilot study of lisdexamfetamine for cocaine use disorder. The American Journal of Drug and Alcohol Abuse 47:3, pages 402-409.
Read now
Paul G Hammerness, Chris Karampahtsis, Ronke Babalola & Mark E Alexander. (2015) Attention-deficit/hyperactivity disorder treatment: what are the long-term cardiovascular risks?. Expert Opinion on Drug Safety 14:4, pages 543-551.
Read now
Vishal Madaan, Venkata Kolli, Durga P Bestha & Manan J Shah. (2013) Update on optimal use of lisdexamfetamine in the treatment of ADHD. Neuropsychiatric Disease and Treatment 9, pages 977-983.
Read now

Articles from other publishers (10)

Iman Idrees, Alessio Bellato, Samuele Cortese & Madeleine J. Groom. (2023) The effects of stimulant and non-stimulant medications on the autonomic nervous system (ANS) functioning in people with ADHD: A systematic review and meta-analysis. Neuroscience & Biobehavioral Reviews 144, pages 104968.
Crossref
Paul Hammerness, Amy Berger, Michael C. Angelini & Timothy E. Wilens. (2022) Cardiovascular Considerations for Stimulant Class Medications. Child and Adolescent Psychiatric Clinics of North America 31:3, pages 437-448.
Crossref
James Ermer, Patrick Martin, Mary Corcoran & Yumiko Matsuo. (2019) A phase 1, randomized, double‐blind, placebo‐controlled study to evaluate the safety, tolerability, and pharmacokinetics of single and multiple doses of lisdexamfetamine dimesylate in Japanese and Caucasian healthy adult subjects. Neuropsychopharmacology Reports 40:1, pages 16-29.
Crossref
Jadwiga Najib, Dexter WimerJulie ZengKristina W LamNatalya RomanyakEva Paige MorganAnu Thadavila. (2017) Review of Lisdexamfetamine Dimesylate in Adults With Attention-Deficit/Hyperactivity Disorder. Journal of Central Nervous System Disease 9, pages 117957351772809.
Crossref
Arthur N. WestoverPaul A. NakoneznyBryon AdinoffEdson Sherwood BrownEthan A. Halm. (2016) Impact of Stimulant Medication Use on Heart Rate and Systolic Blood Pressure During Submaximal Exercise Treadmill Testing in Adolescents. Journal of Child and Adolescent Psychopharmacology 26:10, pages 889-899.
Crossref
Arthur N. Westover, Paul A. Nakonezny, Carolyn E. Barlow, Bryon Adinoff, E. Sherwood Brown, Ethan A. Halm, Wanpen Vongpatanasin & Laura F. DeFina. (2016) Heart Rate Recovery and Systolic Blood Pressure Recovery After Maximal Exercise in Prevalent Users of Stimulant Medications. Journal of Clinical Psychopharmacology 36:3, pages 295-297.
Crossref
James E. Frampton. (2016) Lisdexamfetamine: A Review in ADHD in Adults. CNS Drugs 30:4, pages 343-354.
Crossref
Jefferson B. Prince, Nicholas R. Morrison & Timothy E. Wilens. 2015. Attention-Deficit Hyperactivity Disorder in Adults and Children. Attention-Deficit Hyperactivity Disorder in Adults and Children 276 297 .
David R. Coghill, Beatriz Caballero, Shaw Sorooshian & Richard Civil. (2014) A Systematic Review of the Safety of Lisdexamfetamine Dimesylate. CNS Drugs 28:6, pages 497-511.
Crossref
Jose Martinez-Raga, Carlos Knecht, Nestor Szerman & María I. Martinez. (2012) Risk of Serious Cardiovascular Problems with Medications for Attention-Deficit Hyperactivity Disorder. CNS Drugs 27:1, pages 15-30.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.